Toggle high contrast
Country selector icon United States
  • ATAT
  • AUAU
  • BEBE
  • CACA
  • CHCH
  • CNCN
  • CZCZ
  • DEDE
  • DKDK
  • ESES
  • FIFI
  • FRFR
  • GRGR
  • HRHR
  • HUHU
  • IEIE
  • ILIL
  • ININ
  • ITIT
  • JPJP
  • NLNL
  • NONO
  • PLPL
  • PTPT
  • RORO
  • RURU
  • SESE
  • SkSK
  • TRTR
  • UKUK
  • ZAZA
Medtronic logo
  • Sign In & Bill Pay Drop down arrow icon
    • Bill Pay
    • CareLink™ Website
    • Diabetes.shop
Open Nav Menu Close Nav Menu Menu
Diabetes
Back
Diabetes Overview
Back
Diabetes Overview
What is diabetes
Newly diagnosed
Type 1 diabetes
Type 2 diabetes
Diabetes symptoms
Time in range
Insulin
A1C test
Prediabetes
Gestational diabetes
Glossary
Treatments
Back
Treatments
Insulin pump therapy
Insulin pump therapy for children
Insulin pump therapy for type 2 diabetes
Continuous glucose monitoring (CGM)
CGM for type 2 diabetes
CGM for Veterans
Multiple daily injections (MDI)
Smart MDI
Symptoms of Diabetes
Back
Symptoms of Diabetes
Hypoglycemia (lows)
Hyperglycemia (highs)
Diabetic ketoacidosis (DKA)
Eye care
Foot health
Lumps and bumps
Bruised fingers
Gastroparesis
Painful diabetic peripheral neuropathy
Daily Life
Back
Daily Life
Travel
Diabetes and mental health
Sleep
Work life
Driving safety
Intimacy
Alcohol and diabetes
Steroids and diabetes
Recreational drugs and diabetes
Preparing for a hospital stay
Food and Fitness
Back
Food and Fitness
Carb counting
Nutrition
Grocery shopping
Diabetes and exercise
Diabetes and sports
Diabetes and vitamins
Family & Children
Back
Family & Children
Children and diabetes
Newly diagnosed children
Teenagers and diabetes
Newly diagnosed teens
Newly diagnosed adults
Parent tips
Teacher tips
School
Camps
Sleepover guide
College life
Care partners
Support network
Finding an endocrinologist
Costs & Insurance
Back
Costs & Insurance
Medicare
Insurance terms
Medical costs
Recursos en Español
Back
Recursos en Español
Recursos en Español
Diabetes del tipo 1
Diabetes del tipo 2
Bomba de insulina
El sistema MiniMed™ 780G
El sistema MiniMed™ 770G
El monitero continuoso de glucosa
Inpen™ sistema inteligente de pluma de insulina
MCG y sistema inteligente de pluma de insulina
Sistema Guardian™ Connect
100 años de la insulina
Products
Back
Insulin Pump Systems
Back
MiniMed™ 780G System

Our most advanced system yet.

Learn more
En Español Software upgrade CGM4U program Device compatibility Infusion sets Compare insulin pumps
MiniMed 780G System
MiniMed™ 770G System
MiniMed 770G System
Learn more
MiniMed™ 630G System
MiniMed 630G System
Learn more
Continuous Glucose Monitoring (CGM)
Back
Guardian™ Connect System
Guardian Connect System

For people with type 1 and type 2 diabetes

Learn more What is continuous glucose monitoring? What are the benefits of CGM? Benefits of CGM for type 2 diabetes 30-day evaluation program CGM access program Smart MDI What are the benefits of predictive alerts?
Smart Insulin Pen
Back
InPen™ Smart Insulin Pen
InPen Smart Insulin Pen

For people who take multiple daily injections

Learn more Why InPen™ Get started with InPen™ Smart MDI Clinicians
Injection Port
Back
i-Port Advance™ Injection Port
i-Port Advance Injection Port

Injection port that lets you take your medication without having to puncture your skin for each shot

Learn more 30 day evaluation program Watch video Video Camera Icon Smart MDI
Therapy Management
Back
CareLink™ Software
CareLink Software

Converts data from your device into easy to understand insights about your sugar levels

Learn more Create an account For customers Login CareLink™ software support User guides and manuals FAQs
Future Product Innovations
Support
Back
Product Support
Back
Product Support
MiniMed™ 780G system
MiniMed™ 770G system
MiniMed™ 670G system
MiniMed™ 630G system
MiniMed™ 530G system
Guardian Connect™ CGM system
InPen™ system
i-Port Advance™ injection port
CareLink™ software
Infusion sets
Sensors & transmitters
All products
Medtronic Services
Back
Medtronic Services
Services and support
Financial support programs
My Insights
Why Medtronic
Ordering and billing
Medicare
Pharmacy
Travel
Global assistance
Contact
Financial Support Programs
Back
Financial Support Programs
All programs
CGM4U program
CGM access discount
Flex payment plan
InPen™ access program
Payment relief
User Guides and Manuals
Back
User Guides and Manuals
All user guides and product manuals
Community
Back
Medtronic Champions
Back
Champion Community
Medtronic Champions
Join the community
Connect with an Ambassador
Community Resources
Back
Community Resources
Diabetes community resources
Health equity
Loop blog
Real customer stories
Webinars
Online communities
Video library
Share your ideas
Share your story
Our Company
Back
Our Company
About Medtronic Diabetes
Innovation pipeline
Innovation milestones
Mission Statement
News releases
100 years of insulin
Environmental impact
Health equity
Why Medtronic
Philanthropic partners
Medtronic.com
Contact
Back
How To Reach Us
Back
How To Reach Us
Contact us
International locations
Share your ideas
Get started
Newsletter sign-up
Diabetes.shop
Back
Account sign in
Product training
Bill Pay
Order history
Scheduled orders
Upgrade to Minimed™ 780G system
Communication preferences
Order supplies
Back
Order supplies
Sensors
Infusion sets
Reservoirs
Skins and cases
Belt clips
Replacement requests
Back
Replacement requests
Sensors
Belt clips
Battery cap
Healthcare Professionals
Important Product Safety InformationAlert: Product and Recall Notices
end-of-year-savings

Met your annual insurance deductible?

End-of-Year Savings

Now may be the best time to upgrade to our latest technology with a lower out-of-pocket cost compared to other times during the year.

Act by December 1, 2023*


Get Started

*To help ensure order is processed

En Español

Celebrating
100 years of insulin


About 100 years ago, the discovery of insulin fundamentally changed how diabetes is treated. From improved insulin formulas to glucose monitoring to automated insulin delivery, there have been many inventions over the last century. Medtronic is pleased to have contributed to innovations that have made meaningful improvements to how diabetes is managed.

Celebrating 100 years of insulin is not just about celebrating the past, but about celebrating the future. The means of delivering insulin has evolved from glass syringes to smart insulin pens — from backpack pumps to advanced hybrid closed loop systems that fit on the hip.

insulin at 100

Milestone Timeline


Some of the key advancements that have occurred in diabetes research over the past 100 years with Medtronic pioneering many of the "firsts" and transforming diabetes care.


1921

At the University of Toronto physician, Dr. Frederick Banting, and his partner, Charles H. Best, successfully extracted the hormone insulin from a dogs pancreas. Later they used insulin to treat a dog with diabetes and found it had normalized blood sugar levels.


University of Toronto physician, Dr. Frederick Banting, and his partner, Charles H. Best
1922

Leonard Thompson at Toronto General Hospital becomes the first person with diabetes to be treated with insulin when he was just 14 years old.


Leonard Thompson at Toronto General Hospital becomes the first person with diabetes to be treated with insulin

1950s
  • Researchers identified two distinctive types of diabetes: type 1 diabetes and type 2 diabetes.
  • The first disposable plastic syringe was available. People with diabetes could stop boiling metal needles and glass syringes for each injection of insulin.

Insulin - 1950s

1960s
  • The first successful pancreas transplant took place.
  • Portable glucose meters were introduced.
  • A1C tests became standard.

A1C
1970s

The first synthetic insulin was produced.


Insulin - 1970s

1980s
  • MiniMed launches their 1st insulin pump
  • The first insulin pen was introduced.
  • Home blood glucose meter launched.
1990s
  • MiniMed continues innovation on insulin pumps and infusion sets.
  • Start of clinical trials for glucose sensor.
1999

FDA approves the first-ever physician-use CGM system from Medtronic.

2001

Medtronic acquires MiniMed and furthers the advancements in diabetes care.


Medtronic

2006
  • Medtronic launches 1st CGM for personal use.
  • Medtronic launches world’s 1st sensor-augmented insulin pump.
2009
  • Medtronic launches 1st automatic suspend insulin at preset target insulin pump**.

Medtronic launches 1st CGM for personal use - 2009

2015

Medtronic launches 1st predictive insulin suspend algorithm in an insulin pump.

2016

Medtronic launches 1st hybrid closed loop insulin pump system that automatically* delivers basal insulin.


Medtronic launches 1st hybrid closed loop insulin pump system - 2016

2020
  • Medtronic launches new insulin pump with 5-minute auto-correction boluses
  • Medtronic launches Integrated smart† insulin pen with real-time CGM. This system provides real-time glucose readings alongside insulin dose information.

Medtronic launches new insulin pump with 5-minute auto-correction boluses - 2020

OUR COMMITMENT TO
INNOVATION FOR THE FUTURE


Medtronic remains committed to research and innovation as we play our part in reducing the burden of living with diabetes with solutions for all the ways people want to manage their diabetes around the world.

Medtronic is working together with the global community to change the way people manage diabetes. We aim to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.

“We want to be an outstanding partner for those living with diabetes. To do this, we listen to the community and partner to find ways to drive innovation in everything we do. From new product development to support that is centered around what people want and need, we are committed to making the lives of those living with diabetes easier.”

Sean Salmon, Executive Vice President and President of the Diabetes business at Medtronic

SEAN SALMON, Executive Vice President and President, Diabetes Group

What are you able to do thanks to the discovery of insulin?

#ThankYouInsulin


Left arrow
Right arrow
  • Thank you insulin 1
  • Thank you insulin 2
  • Thank you insulin 3
  • Thank you insulin 4
  • Thank you insulin 5
  • Thank you insulin 6
  • Thank you insulin 7

OUTCOMES
THAT MATTER

OUTCOMES THAT MATTER

SUPPORT
YOU CAN COUNT ON

OUTCOMES THAT MATTER

INNOVATION
FOR THE FUTURE

OUTCOMES THAT MATTER

RELATED
ARTICLES

  • Milestones in Diabetes
  • Insulin 100 - Celebrating a Century of Health Innovation at the University of Toronto
  • 100 years of Insulin
  • Medtronic Innovation Milestones
  • The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead
  • Artificial intelligence: The next frontier in diabetes therapy

* Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.
**Approved for use only outside the US
† Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.


Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Important Safety Information: MiniMed™ InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.

Rx only. Under age 7 requires supervision of an adult caregiver. User interaction, compatible device, proper pairing and settings required. See http://bit.ly/InPenSafety

Important Safety Information >
Labeling Symbols >
  • Home
  • Contact Us
  • Healthcare Professionals
  • myHome
  • Diabetes.shop
  • Patient Bill of Rights
  • Patents
  • Sitemap
  • Digital Millennium Copyright Act (DMCA)

  • Services
  • Services Overview

  • Diabetes Care
  • About Diabetes
  • Diabetes Glossary
  • Getting Started with CGM
  • Diabetic Ketoacidosis (DKA)
  • Hypoglycemia Unawareness
  • Carb Counting
  • Benefits of CGM
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Diabetes and Driving
  • Time-in-Range
  • Symptoms and Complications
  • Work Life with Diabetes
  • CGM for Type 2 Diabetes
  • Products
  • CONTOUR®NEXT LINK Glucose Meter
  • CareLink™ Software
  • Continuous Glucose Monitoring
  • Device Upgrade
  • InPen™ Smart Insulin Pen
  • Guardian™ Connect CGM System
  • Infusion Sets
  • i-Port™ Advance Injection Port
  • Medtronic Extended™ infusion set
  • MiniMed™ 780G System
  • MiniMed™ 770G System
  • MiniMed™ 630G System
  • Smart MDI
  • Sistema InPen™
  • Sistema MiniMed™ 780G
  • Style & Accessories

  • Treatments
  • Continuous Glucose Monitoring
  • Children & Pump Therapy
  • Insulin Pump Therapy
  • Insulin Pump Therapy for Type 2 Diabetes
  • CGM for Type 2 Diabetes
  • CGM for Veterans
  • Support
  • MiniMed™ 780G System Support
  • MiniMed™ 770G System Support
  • MiniMed™ 670G System Support
  • MiniMed™ 630G System Support
  • MiniMed™ 530G System Support
  • MiniMed™ Revel Insulin Pump Support
  • Guardian™ Connect CGM System Support
  • InPen™ System Support
  • CareLink™ Software Support
  • i-Port Advance™ Injection Port
  • Infusion Set Support
  • Equipment Interference
  • Sensors & Transmitters Support
  • Insertion Site Management
  • Ordering & Billing
  • Travel
  • User Guides & Manuals
  • Community
  • Connect with a Medtronic Ambassador
  • Diabetes Online Communities
  • Real-Life Stories
  • Subscribe to Email Newsletter
  • The LOOP Blog
  • Video Library
  • Share Your Idea

  • Medtronic Innovation
  • About Us
  • Careers
  • Innovation Pipeline
  • Innovation Milestones
  • Mission Statement
  • News Releases
  • Media Kits

  • Medtronic Access Programs
  • Medtronic Assurance
  • CGM4U Program
  • CGM Access Discount
  • Flex Payment Plan
  • Facebook icon for Facebook
  • Instagram icon for Instagram
  • Twitter icon for Twitter
  • Tiktok icon for TikTok
  • YouTube icon for YouTube
  • LinkedIn icon for LinkedIn

© Medtronic. All rights reserved. Medtronic, Medtronic logo and Engineering the extraordinary are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Phone icon 1-800-646-4633
Medtronic logo with tagline Engineering the extraordinary
Terms of Use   |   Notice of Privacy Practices   |   Website Privacy Policy